NOTE: All events are in Eastern Daylight Time Zone. Please visit your Symposium Profile to verify your time zone. We recommend displaying all times in the event time zone.
Curative Options in Sickle Cell Disease Plenary Session
Director, Stem Cell Transplant and Cellular Therapy Program
Co-Director, Sickle ell Center of Excellence Vanderbilt University Medical Center Vanderbilt University Medical Center Nashville, Tennessee, United States
Disclosure(s):
Adetola Kassim, M.B.B.S, MS, FACP: No financial relationships to disclose
Learning Objectives:
Understand recent updates on the use of haploidentical hematopoietic stem cell transplant as a curative modality for sickle cell disease
Upon completion, participants will understand the indication for considering haploidentical hematopoietic stem cell transplant as a curative modality for sickle cell disease
Challenges and pitfalls of haploidentical hematopoietic stem cell transplant as a curative modality for sickle cell disease
